Teemu J Niiranen1,2,3,4, Mir Henglin5,6, Brian Claggett5,6, Vito M R Muggeo7, Elizabeth McCabe5,6, Mohit Jain8, Ramachandran S Vasan1,9,10, Martin G Larson1,11, Susan Cheng1,5,6. 1. Framingham Heart Study, Boston University, Framingham, Massachusetts. 2. Division of Medicine, Turku University Hospital, Turku, Finland. 3. Department of Medicine, University of Turku, Turku, Finland. 4. Department of Public Health Solutions, National Institute for Health and Welfare, Turku, Finland. 5. Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts. 6. Harvard Medical School, Boston, Massachusetts. 7. Dipartimento di Scienze Economiche, Aziendali e Statistiche, Universita' di Palermo, Italy. 8. Department of Medicine, University of California-San Diego, La Jolla. 9. Division of Cardiology, Department of Medicine, Boston University, Boston, Massachusetts. 10. Division of Preventive Medicine, Department of Medicine, Boston University, Boston, Massachusetts. 11. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Abstract
Importance: Given that hypertension remains a leading risk factor for chronic disease globally, there are substantial ongoing efforts to define the optimal range of blood pressure (BP). Objective: To identify a common threshold level above which BP rise tends to accelerate in progression toward hypertension. Design, Setting, and Participants: This longitudinal, community-based epidemiological cohort study of adults enrolled in Framingham, Massachusetts, included 1252 participants (mean [SD] age, 35.3 [2.7] years) from the Framingham Original Cohort, of whom 790 (63.1%) were women. Each participant contributed up to 28 serial examinations of standardized resting BP measurements between 1948 and 2005. Exposures: Age and systolic BP. Main Outcomes and Measures: Via a segmented mixed model, we identified significant change points in the association between advancing age and increasing systolic BP among individuals categorized by their age at hypertension onset. Results: Individuals maintained a relatively stable resting systolic BP level prior to hypertension onset. Systolic BP level began to rise at a more rapid rate after reaching a level of 123.2 mm Hg (95% CI, 122.7-130.1 mm Hg) in people with onset at 40 to 49 years; 122.0 mm Hg (95% CI, 120.3-123.9 mm Hg) in those with onset between 50 and 59 years, 124.9 mm Hg (95% CI, 120.2-127.9 mm Hg) in those with onset between 60 and 69 years, and 120.5 mm Hg (95% CI, 118.0-123.2 mm Hg) in those with onset between 70 and 79 years (P = .29 for between-group heterogeneity). Conclusions and Relevance: We observed that individuals in the community generally maintained a systolic BP of less than 120 to 125 mm Hg, above which systolic BP increased at a relatively rapid rate toward overt hypertension. This trend was consistent whether the hypertension manifested earlier or later in life. Thus, a resting systolic BP that chronically exceeds the range of approximately 120 to 125 mm Hg may represent an important threshold of underlying vascular remodeling and signal incipient hypertension irrespective of age. Further investigations are needed to unravel the sequence of hemodynamic and vascular changes occurring prior to hypertension onset.
Importance: Given that hypertension remains a leading risk factor for chronic disease globally, there are substantial ongoing efforts to define the optimal range of blood pressure (BP). Objective: To identify a common threshold level above which BP rise tends to accelerate in progression toward hypertension. Design, Setting, and Participants: This longitudinal, community-based epidemiological cohort study of adults enrolled in Framingham, Massachusetts, included 1252 participants (mean [SD] age, 35.3 [2.7] years) from the Framingham Original Cohort, of whom 790 (63.1%) were women. Each participant contributed up to 28 serial examinations of standardized resting BP measurements between 1948 and 2005. Exposures: Age and systolic BP. Main Outcomes and Measures: Via a segmented mixed model, we identified significant change points in the association between advancing age and increasing systolic BP among individuals categorized by their age at hypertension onset. Results: Individuals maintained a relatively stable resting systolic BP level prior to hypertension onset. Systolic BP level began to rise at a more rapid rate after reaching a level of 123.2 mm Hg (95% CI, 122.7-130.1 mm Hg) in people with onset at 40 to 49 years; 122.0 mm Hg (95% CI, 120.3-123.9 mm Hg) in those with onset between 50 and 59 years, 124.9 mm Hg (95% CI, 120.2-127.9 mm Hg) in those with onset between 60 and 69 years, and 120.5 mm Hg (95% CI, 118.0-123.2 mm Hg) in those with onset between 70 and 79 years (P = .29 for between-group heterogeneity). Conclusions and Relevance: We observed that individuals in the community generally maintained a systolic BP of less than 120 to 125 mm Hg, above which systolic BP increased at a relatively rapid rate toward overt hypertension. This trend was consistent whether the hypertension manifested earlier or later in life. Thus, a resting systolic BP that chronically exceeds the range of approximately 120 to 125 mm Hg may represent an important threshold of underlying vascular remodeling and signal incipient hypertension irrespective of age. Further investigations are needed to unravel the sequence of hemodynamic and vascular changes occurring prior to hypertension onset.
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 10.190
Authors: Majd AlGhatrif; James B Strait; Chris H Morrell; Marco Canepa; Jeanette Wright; Palchamy Elango; Angelo Scuteri; Samer S Najjar; Luigi Ferrucci; Edward G Lakatta Journal: Hypertension Date: 2013-09-03 Impact factor: 10.190
Authors: Nicholas Stroustrup; Winston E Anthony; Zachary M Nash; Vivek Gowda; Adam Gomez; Isaac F López-Moyado; Javier Apfeld; Walter Fontana Journal: Nature Date: 2016-01-27 Impact factor: 49.962
Authors: Teemu J Niiranen; Elizabeth L McCabe; Martin G Larson; Mir Henglin; Neal K Lakdawala; Ramachandran S Vasan; Susan Cheng Journal: BMJ Date: 2017-05-12
Authors: Teemu J Niiranen; Elizabeth L McCabe; Martin G Larson; Mir Henglin; Neal K Lakdawala; Ramachandran S Vasan; Susan Cheng Journal: Eur Heart J Date: 2017-08-01 Impact factor: 29.983
Authors: Elaine M Urbina; Philip R Khoury; Lydia Bazzano; Trudy L Burns; Stephen Daniels; Terrence Dwyer; Tian Hu; David R Jacobs; Markus Juonala; Ronald Prineas; Olli Raitakari; Julia Steinberger; Alison Venn; Jessica G Woo; Alan Sinaiko Journal: Hypertension Date: 2019-06 Impact factor: 10.190
Authors: Jan A Staessen; Lutgarde Thijs; Wen-Yi Yang; Cai-Guo Yu; Fang-Fei Wei; Harry A Roels; Tim S Nawrot; Zhen-Yu Zhang Journal: Hypertension Date: 2020-02-03 Impact factor: 10.190
Authors: Harpreet Kaur; Dana C Crawford; Jingjing Liang; Penelope Benchek; Xiaofeng Zhu; Asha R Kallianpur; William S Bush Journal: PLoS One Date: 2021-11-18 Impact factor: 3.240
Authors: Hongwei Ji; Andy Kim; Joseph E Ebinger; Teemu J Niiranen; Brian L Claggett; C Noel Bairey Merz; Susan Cheng Journal: Hypertension Date: 2020-02-17 Impact factor: 9.897